Staying Ahead of Reporting Regulations [Webinar]
NORTHAMPTON, MA / ACCESSWIRE / March 12, 2024 / Workiva
Staying Ahead of Reporting Regulations
Thursday, March 14th
11:00 A.M. - 12:00 P.M. ET
Join Workiva and PwC for a webinar exploring the results of the 2024 Executive Benchmark on Integrated Reporting, a survey of more than 800 corporate executives and 100 institutional investors across North America. Leaders from both organizations will discuss how financial and ESG reporting are evolving amid new regulations-including the SEC's climate disclosure rule.
Attendees can earn one complimentary CPE credit for their participation.
View additional multimedia and more ESG storytelling from Workiva on 3blmedia.com.
Contact Info:
Spokesperson: Workiva
Website: https://www.3blmedia.com/profiles/workiva
Email: info@3blmedia.com
SOURCE: Workiva
View the original press release on accesswire.com
-
5 Undervalued Stocks to Buy to Play a Little Defense
-
Markets Brief: AI Leaders Excel In Earnings Season So Far
-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
After Earnings, Is Tesla Stock a Buy, a Sell, or Fairly Valued?
-
After Earnings, Is GE Aerospace Stock a Buy, a Sell, or Fairly Valued?
-
3 Good Stocks to Buy with Your Tax Refund in 2024 (Or with Any Extra Money)
-
SoFi Earnings: Revenue Growth Slows on Lower Loan Growth and Higher Credit Costs
-
Tesla: Full Self-Driving Approval In China Supports Our View for Deliveries Growth In 2024
-
Philips Earnings: Firm Reaches $1.1 Billion Settlement Agreement
-
AbbVie Earnings: Next-Generation Immunology Drugs Help Offset Humira Biosimilar Pressure
-
Exxon Earnings: Ignore Earnings Shortfall as Long-Term Growth and Improvement on Track